Add your name to join more than 150,000 people and more than 70 groups who are demanding that the CEOs of Boehringer Ingelheim Pharmaceuticals Inc., Bristol Myers Squibb Co., Janssen Pharmaceuticals Inc., Merck, Novartis Pharmaceuticals Co., and Novo Nordisk withdraw their lawsuits attempting to block drug price negotiation provisions under the Inflation Reduction Act.

Medicare’s ability to negotiate drug prices is a critical step toward making medications more affordable for millions of Americans, especially seniors and those with limited financial resources. Big Pharma's actions undermine the fundamental principle that everyone deserves the medication they need at prices they can afford.

As concerned patients, citizens, and advocates for affordable drugs, we are outraged by their current legal action to attempt to prevent Medicare from negotiating prices for some of its costliest drugs.